Diana Aguiar de Sousa, MD, PhD, University of Lisbon, Santa Maria Hospital, Lisbon, Portugal, discusses predicting outcomes and treatment responsiveness after cerebral venous thrombosis (CVT). Currently, there are scoring systems and prognostic factors which have emerged from cohort studies of patients with CVT. However, the disease is unpredictable, especially in the acute phase. It is difficult to predict which patients will have worse long-term outcomes and are likely to have an unfavourable course during the acute phase. Further research should be undertaken to uncover predictive markers for these patients, as these groups are more likely to benefit from more aggressive intervention during the acute phase. This interview took place during the European Stroke Organisation Conference (ESOC) in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.